Evaluation of the effects of resveratrol in patients with Covid ??
- Conditions
- Covid-19.COVID-19, virus identified
- Registration Number
- IRCT20111119008129N13
- Lead Sponsor
- Boushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Female and Male with the age between 18 to 55 years
Long involvement approved by city scan
Admitted to the hospital with Fever( = 38 C°)
The breath rate = 24/min, or coughing ( before the 8th day of the disease )
Infection with covid 19, approved by PCR
Pregnant women
Patients with kidney Disease,
Patients with hypercalcemia and hypercalciuria
Patients with any type of allergic diseases
Having any kind of disease by which the patients can't have a proper participation
Inability to behave properly( having Mental problem
Auto immune diseases ( having MS, Lupus ...)
Kidney Failure, Hepatitis B and C
Patients with acute covid 19 symptoms
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary involvement. Timepoint: The time of measurement will be after interventions for a period of 10 days, for all the participants in both groups. Method of measurement: Results of CT scan (chest radiography).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.